Raymond James Cuts RNST as Shorts Hold at One-Year High

Renasant Corporation collected a Raymond James downgrade this morning, the day after Q3 earnings landed and the stock fell 3.7%. The rating moves from Strong Buy to Outperform, with the price target cut to $45 from $50.

That target still sits 12% above yesterday's close of $40.19. But the direction of travel matters. TD Cowen trimmed its own target to $46 from $49 three weeks ago while holding its Buy rating. Both firms remain constructive on the name; both have been marking down their views.

What the Short Side Tells You

Short interest has reached 6.0% of free float, the highest reading in at least a year. Positions rose 11.2% in the past week and nearly 24% over the past month. None of that build was forced. Availability stands at 1,254% of outstanding short interest: for every share already borrowed, more than twelve more sit available to lend. The cost to borrow is 0.42%, comfortably low. Shorts accumulated these positions on their own terms.

The ORTEX short score has drifted to 52.2 from 49.4 ten days ago. The move is modest but consistent, tracking the flow of new short positioning rather than any single session.

Meanwhile, peers have had a better week. The closest correlated regional banks gained 2.9% to 6.6% over the past seven days. RNST was flat over the same stretch, down 0.3%.

Call Buyers Held Firm Through the Print

The put/call ratio remained at 0.037 as of October 28, 2.1 standard deviations below its 20-day mean of 0.127. That reading held for three consecutive sessions through and after the earnings date. The 52-week range runs from 0.0018 to 0.8456. At 0.037, the options market is almost entirely calls. Post-earnings, that positioning has not unwound.

Retail attention added another layer. Wikipedia page views and ORTEX stock page views combined to put attention 2.54 standard deviations above Renasant's own 90-day baseline as of October 24.

FDIC Data Shows the Bank's Own Numbers

ORTEX alt data drawn from FDIC call reports shows Renasant's net income rose for four consecutive quarters through Q2 2026. The Q2 reading of $94.3 million was 1,106% above the same quarter a year earlier, reflecting the impact of an acquisition on the year-on-year comparison. The FDIC dataset has not been shown to lead the company's reported figures, so it is context rather than a read on the next print.

---

• Short interest: 6.0% of free float, highest in at least one year, up 11.2% over one week and 23.8% over one month
• Availability: 1,254% of outstanding short interest; cost to borrow 0.42%
• Raymond James: downgrades to Outperform from Strong Buy, target $45 from $50
• TD Cowen: maintains Buy, target $46 from $49 (October 5)
• Put/call ratio: 0.037, 2.1 standard deviations below the 20-day mean of 0.127
• Stock move: -3.7% on earnings day; -0.3% over one week versus a peer median of +3.4%